1. Home
  2. CABR vs ASBP Comparison

CABR vs ASBP Comparison

Compare CABR & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caring Brands Inc.

CABR

Caring Brands Inc.

N/A

Current Price

$1.26

Market Cap

12.8M

ML Signal

N/A

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

N/A

Current Price

$8.32

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CABR
ASBP
Founded
2020
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
12.4M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
CABR
ASBP
Price
$1.26
$8.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.7K
★ 28.4K
Earning Date
11-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $4,215.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.05
52 Week High
$1.84
$9.50

Technical Indicators

Market Signals
Indicator
CABR
ASBP
Relative Strength Index (RSI) 43.38 47.66
Support Level $1.07 $7.88
Resistance Level $1.33 $9.37
Average True Range (ATR) 0.07 0.56
MACD -0.00 -0.04
Stochastic Oscillator 23.09 28.85

Price Performance

Historical Comparison
CABR
ASBP

About CABR Caring Brands Inc.

Caring Brands Inc is a wellness consumer products company. It offers several over-the-counter (OTC) and cosmetic consumer products. Its product pipeline includes a diverse products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products, catering to diverse health and wellness needs. It operates in a single segment.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Share on Social Networks: